In 207 patients with early Parkinson's disease on levodopa without motor complications, adjunct amantadine-IR 200 mg/day vs placebo reduced dyskinesia incidence over 18 months (11% vs 22%, P=0.025); differences after delayed start and washout were not significant.
RCTn = 207
Rascol et al. Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)